Still ordering hydralazine? 🤔
Beyond case reports, this large cohort compares hydralazine vs ACEi/ARB to estimate real-world vasculitis risk, will this 📉 bias & clarify the answer
Read more 👇
pubmed.ncbi.nlm.nih....
#TenPostNephJC #NephJC
#NephSky #MedSky
Evaluating Long-Term Outcomes Across eGFR Equations in Older Adults - Kidney International Reports www.kireports.org/article/S246...
The #ISNWCN has high trial impact clinical trials to celebrate latest and more successful results in our nephro world
To celebrate the joy of getting together, and to #NephItForward, we officially opened up the #NephJC Editorial Internship application
www.nephjc.com/news/nephjc-...
This is figure 1, which shows plastic waste recycling and bio-upcycling strategies.
A paper in Nature Sustainability presents an approach to upcycle plastic waste through microbial conversion into levodopa, a medicine for Parkinson’s disease. go.nature.com/4ryglvx 🧪
Time to Treatment Discontinuation among Apixaban Users and Time to Initiation of Oral Anticoagulation Among Matched Non-Users. Note: OAC – oral anticoagulant. Apixaban users (in red) had filled their first apixaban prescription within 30 days from their new diagnosis with atrial fibrillation. Continued use was present when a subsequent apixaban prescription was filled within no more than 7 days after the most recent supply was exhausted. If no refill occurred, 7 days were added to the most recent days’ supply. Apixaban use also ended when a prescription for a different OAC was filled. Non-users (in blue) of an oral anticoagulant within the same number of days from their new diagnosis with atrial fibrillation as their matched apixaban user were followed for any subsequent initiation of any oral anticoagulant.
Effectiveness and Safety of Apixaban Initiation Following Newly-Diagnosed Atrial Fibrillation in Patients With Kidney Failure on Hemodialysis
bit.ly/44IMgkk
Still using Cockcroft-Gault for dosing decisions?
This new course examines its limitations and what clinicians need to know as practice shifts to race-free eGFR.
bit.ly/3PQuiYv
#KidneyHealth #Nephrology #ContinuingEducation
New dyslipidemia guidelines have finally arrived! So much is new & improved compared to prior US guidelines! A broader understanding of lipid risk/reatment (beyond cholesterol), improved thinking about younger adults & lifetime prevention, & so much more! #CardioSky
www.jacc.org/doi/10.1016/...
Shellie Fravel joining from Iowa City. No COI, excited to learn a few things tonight! #nephjc
New Podcast: Dr. McCausland summarizes the main findings from his study on "Effect of finerenone on eGFR slope across different levels of baseline albuminuria and eGFR: Insights from FINEARTS-HF" #ASNCJASN kidney.pub/CPOD0849
Original Article | MAR 11, 2026 Finerenone in Type 1 Diabetes and Chronic Kidney Disease (FINE-ONE) Figure 1. Change in the Urinary Albumin-to-Creatinine Ratio.
In adults with type 1 diabetes and chronic kidney disease with albuminuria, the decrease in the urinary albumin-to-creatinine ratio was significantly greater with finerenone than with placebo. Full phase 3 FINE-ONE trial results: nej.md/4rTPAmu
#MedSky #EndoSky #Nephrology
Use of auto BP devices is rec'd by guidelines but many still measure BP manually. In this preprint, we categorize BP device based on terminal digit (manual BP results in even # terminal digits). Manual BP ~6mmHg lower and associated with 1.16x stroke risk vs automated www.medrxiv.org/content/10.6...
This is topic 1b not a 1B graded suggestion, because the data I'm seeing that this is a make believe problem. Further damning of iron by ESA pushers.
#ShowMeTheEvidence
#NephJC
Sliding in a little late! Shellie Fravel, pharmacist joining from iowa city. No COI. #nephjc
#NephSky #MedSky
🩸Blood is thicker than water 🌊
Thankfully we thinned out the 2026 KDIGO Anemia Guidelines for you to peruse.
Come discuss what's new.
Tuesday 2/24/26 at 9pm EST on Bluesky!
Summary by @jeyakumarmeyyappan.bsky.social
www.nephjc.com/news/kdigo-anemia
Hey #MedSky #NephSky
KDIGO has updated their guidance on anemia in kidney disease for the first time in a decade! Let's discuss 2/24/26 at 9pm EST
Check out the VA by @shelliefravel.bsky.social
www.nephjc.com/news/2026/2/23/kdigo-2026-anemia-in-ckd
GFR Measured With Computerized Tomography Urography in Healthy Individuals and Patients With CKD
bit.ly/3XsLlQY #OpenAccess
Shellie Fravel, pharmacist joining from Iowa City, no COI #nephjc
Excited to share our research letter published today in JAMA on the new Apple Watch Hypertension Notification Feature! jamanetwork.com/journals/jam...
1/n
Hey #NephSky
2/10/26 at 9 pm EST we'll discuss
#Flozinating into the Future & Beyond...
SGLT2i in kidney transplant recipients.
What's the latest evidence of risk/benefit?
Do #Flozins act mechanistically the same in de-innervated kidneys?
Come chat.
www.nephjc.com/news/inifinti-flozins-transplant
PBFluids▶️PISCES showed a striking cardiovascular benefit with fish oil in hemodialysis. Lovaza closely matches the trial’s ethyl-ester formulation, is FDA regulated, EHR friendly, and offers a practical option while we wait for the exact formulation pbfluids.com/2026/01/why-...
Up next on #NephJC we will be unpacking SGLT2i in transplant recipients👇
journals.lww.com/cja...
Shellie Fravel, pharmacist signing on from Iowa City, no COI #nephjc
🍌🥑Can pushing K⁺ to the high-normal range reduce ICD shocks and hospitalizations?
🎨 #Visualabstract by @jeyakumarmeyyappan.bsky.social
⏰ #NephJC chat on Jan 27, 9 pm EST
www.nephjc.com/news/2026/1/...
Oh, the weather outside is frightful 🥶🥶
But #NephJC is so delightful,
and since you've no place to go #NephSky...
Come discuss POTCAST: potassium goals and cardiac arrhythmias 1/27/26 at 9pm EST on #Bluesky
Summary by @shelliefravel.bsky.social @salinesolut.bsky.social
www.nephjc.com/news/potcast
Sodium-Glucose Cotransporter-2 Inhibitors #SGLT2i and #Cardiorenal Events in #Nonalbuminuric Kidney Disease
#VisualAbstract by Augusto Cesar S Santos Jr
www.kireports.org/article/S2468-0249(25)00...
@cwhuang0824
Can measuring glomerular filtration finally be easy?
#nephsky #nephrology
www.kireports.org/article/S246...
It's 2026!🎉
We will be counting down the Top Ten Nephrology Stories of 2025 on 1/6/26 at 9 pm EST.
Join us on TWITTER (it will always be Twitter to us).
Come on by #NephJC faithful for a lively discussion! You picked & we're count'em down.
www.nephjc.com/news/2025/1/3/top-stories-in-nephrology-2025
Did we (meaning "you" of course, because you voted) get them right? Is there something missing or is the order wrong? #NephJC #TopTenStories2025
Come discuss with an international cadre of nephrologists & other interested parties on 1/6/26 at 9 pm EST on #Twitter
The future of nephrology
1/10
Last #NephJC we discussed dialysis frequency in AKI-D #TenPostNephJC
We sought to answer an age-old question: Is less is really more? Or less is just simply what it is….less?
pubmed.ncbi.nlm.nih.gov/41201895/